In the last 12 months, insiders at Scribe Therapeutics made open-market purchases of $56.26 million (3.72Mn shares) and sold no shares on the open market.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Behzad Aghazadeh | Director, TenPercentOwner, Other | 0 | 3,088,888 | 3,088,888 | 32.6% | 28 Jul, 2026 |
| 2 | Bio Fund Ii, L.P. Ah | TenPercentOwner | 0 | 3,082,725 | 3,082,725 | 32.5% | 29 Jul, 2026 |
| 3 | Advisors Llc Orbimed | Director | 0 | 1,348,825 | 1,348,825 | 14.2% | 29 Jul, 2026 |
| 4 | Carl L Gordon | Director | 0 | 1,348,825 | 1,348,825 | 14.2% | 29 Jul, 2026 |
| 5 | Jennifer A Doudna | TenPercentOwner | 603,547 | 0 | 603,547 | 6.4% | 29 Jul, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 27 Jul, 2026 | Bio Fund Ii, L.P. Ah | TenPercentOwner | Acquired C | 2,051,742 | — | — | 2,051,742 | Indirect |
| 27 Jul, 2026 | Advisors Llc Orbimed | Director | Acquired C | 348,825 | — | — | 348,825 | Indirect |
| 27 Jul, 2026 | Carl L Gordon | Director | Acquired C | 348,825 | — | — | 348,825 | Indirect |
| 27 Jul, 2026 | Jennifer A Doudna | TenPercentOwner | Acquired C | 12,511 | — | — | 603,547 | Direct |
| 27 Jul, 2026 | Advisors Llc Orbimed | Director | Acquired P | 1,000,000 | $15.00 | $15.00Mn | 1,348,825 | Indirect |
| 27 Jul, 2026 | Bio Fund Ii, L.P. Ah | TenPercentOwner | Acquired C | 697,650 | — | — | 697,650 | Indirect |
| 27 Jul, 2026 | Carl L Gordon | Director | Acquired P | 1,000,000 | $15.00 | $15.00Mn | 1,348,825 | Indirect |
| 27 Jul, 2026 | Jennifer A Doudna | TenPercentOwner | Disposed C | 74,088 | — | — | 0 | Direct |
| 27 Jul, 2026 | Advisors Llc Orbimed | Director | Disposed C | 2,065,672 | $0.00 | $0 | 0 | Indirect |
| 27 Jul, 2026 | Carl L Gordon | Director | Disposed C | 2,065,672 | $0.00 | $0 | 0 | Indirect |
| 27 Jul, 2026 | Bio Fund Ii, L.P. Ah | TenPercentOwner | Acquired P | 333,333 | $15.00 | $5.00Mn | 2,385,075 | Indirect |
| 27 Jul, 2026 | Bio Fund Ii, L.P. Ah | TenPercentOwner | Disposed C | 12,150,003 | $0.00 | $0 | 0 | Indirect |
| 27 Jul, 2026 | Bio Fund Ii, L.P. Ah | TenPercentOwner | Disposed C | 4,131,344 | $0.00 | $0 | 0 | Indirect |
| 24 Jul, 2026 | Behzad Aghazadeh | Director, TenPercentOwner, Other | Acquired P | 2,333,333 | $15.00 | $35.00Mn | 3,030,983 | Indirect |
| 24 Jul, 2026 | Behzad Aghazadeh | Director, TenPercentOwner, Other | Acquired P | 50,000 | $22.31 | $1.12Mn | 3,080,983 | Indirect |
| 28 Jul, 2026 | Behzad Aghazadeh | Director, TenPercentOwner, Other | Acquired P | 7,905 | $18.25 | $144.27K | 3,088,888 | Indirect |
| 23 Jul, 2026 | James Dean Watson | Director | Acquired A | 14,725 | $0.00 | $0 | 14,725 | Direct |
| 23 Jul, 2026 | Carl L Gordon | Director | Acquired A | 14,725 | $0.00 | $0 | 14,725 | Direct |
| 23 Jul, 2026 | Behzad Aghazadeh | Director, Other | Acquired A | 14,725 | $0.00 | $0 | 14,725 | Direct |
| 23 Jul, 2026 | Joshua Bleharski | Director | Acquired A | 14,725 | $0.00 | $0 | 14,725 | Direct |